New cell therapy trial offers hope for Tough-to-Treat sarcomas
NCT ID NCT06083883
Summary
This early-stage study is testing a new treatment for people with advanced synovial sarcoma or myxoid/round cell liposarcoma. Researchers are giving patients donated immune cells (NK cells) that have been specially engineered to find and attack cancer. The main goals are to find a safe dose and see if the therapy can shrink tumors in patients whose cancer has come back after standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYNOVIAL SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.